摘要
目的探析老年肺部感染患者接受头孢唑肟治疗的临床疗效。方法该文选取2014年9月-2020年9月该院收治的61例老年肺部感染患者为研究对象,经数表法分组,接受头孢地嗪治疗的患者为对照组(n=30),接受头孢唑肟治疗的患者为研究组(n=31),对比患者临床症状及感染指标改善情况,分析疗效差异。结果患者经临床治疗,观察组咳嗽气喘消失时间(5.46±1.19)d、退热(1.82±0.31)d、肺部啰音消失(2.53±1.64)d,均少于对照组,差异有统计学意义(t=6.257、15.020、5.708,P<0.05)。患者经治疗,研究组疗效总有效率96.77%高于对照组73.33%,差异有统计学意义(χ^(2)=4.927,P<0.05)。患者经治疗,研究组患者白细胞计数(8.16±2.33)×10^(9)/L、CRP(11.95±3.86)mg/L,均优于对照组,差异有统计学意义(t=2.983、4.589,P<0.05)。结论老年肺部感染患者经头孢唑肟治疗,患者的临床症状与感染指标得到了明显改善,临床治疗效果好。
Objective To analyze the clinical efficacy of ceftizoxime in elderly patients with lung infection.Methods This article selected 61 elderly patients with lung infections admitted to the hospital from September 2014 to September2020 as the research objects.They were grouped by the digital table method,and the patients treated with cefodizime were selected as the control group(n=30).The patients who received ceftizoxime treatment were the study group(n=31).The improvement of clinical symptoms and infection indexes of the patients was compared,and the difference in curative effect was analyzed.Results After clinical treatment,the observation group’s cough and asthma disappearance time(5.46±1.19)d,fever reduction(1.82±0.31)d,lung rales disappeared(2.53±1.64)d,all of which were less than those of the control group.The difference was statistically significant(t=6.257,15.020,5.708,P<0.05).After treatment,the total effective rate of the study group 96.77%was higher than that of the control group 73.33%,and the difference was statistically significant(χ^(2)=4.927,P<0.05).After the patients were treated,the white blood cell count(8.16±2.33)×10^(9)/L and CRP(11.95±3.86)mg/L of the study group were better than those of the control group,and the difference was statistically significant(t=2.983,4.589,P<0.05).Conclusion The clinical symptoms and infection indicators of the elderly patients with lung infection have been treated with ceftizoxime,and the clinical treatment effect is good.
作者
阮红
RUAN Hong(Department of Geriatrics,People's Hospital of Liuhe District,Nanjing,Jiangsu Province,211500 China)
出处
《系统医学》
2021年第16期152-154,共3页
Systems Medicine
关键词
老年肺部感染
头孢唑肟
疗效
Elderly lung infections
Ceftizoxime
Curative effect